Sievers B, Shi W, Hu J, Miller R, Patel N, Van Nostrand K
J Med Case Rep. 2025; 19(1):92.
PMID: 40033425
PMC: 11877761.
DOI: 10.1186/s13256-025-05116-2.
Burkhardt A, Smith C, Singh R
Diagnostics (Basel). 2025; 15(3).
PMID: 39941320
PMC: 11817209.
DOI: 10.3390/diagnostics15030390.
Guo Y, Huang Q, Heng Y, Zhou Y, Chen H, Xu C
MedComm (2020). 2025; 6(2):e70079.
PMID: 39901896
PMC: 11788016.
DOI: 10.1002/mco2.70079.
Liu X, Yin H, Shen H, Wang X, Zhang Z, Yuan X
Front Endocrinol (Lausanne). 2025; 15:1501142.
PMID: 39866732
PMC: 11757122.
DOI: 10.3389/fendo.2024.1501142.
Muntean C, Solomon A, Cipaian R, Vonica R, Butuca A, Gaborean V
J Clin Med. 2025; 14(2.
PMID: 39860342
PMC: 11765571.
DOI: 10.3390/jcm14020338.
Unveiling the Malignancy Risk of Surgically Treated Bethesda III Thyroid Nodules: A 10-Year Retrospective Study Comparing Fine-Needle Aspiration Cytology (FNAC) and Histopathology.
Rafi M, Kanwal M, Awais M, Ahmad T, Tayyab M, Naem M
Cureus. 2025; 16(12):e75855.
PMID: 39822453
PMC: 11736669.
DOI: 10.7759/cureus.75855.
Propensity analysis reveals survival disparities between T1a and T1b well-differentiated thyroid cancer based on surgery.
Landau M, Hussein M, Herrera M, Linhuber J, Toraih E, Kandil E
Gland Surg. 2025; 13(12):2335-2347.
PMID: 39822359
PMC: 11733632.
DOI: 10.21037/gs-24-327.
Investigating papillary thyroid cancer risk factors among women living at the central region of Iran: a case-control study.
Ghoshouni H, Hosseini S, Ghadiri-Anari A, Azizi R, Rahmanian M, Hazar N
BMC Endocr Disord. 2025; 25(1):12.
PMID: 39819284
PMC: 11737264.
DOI: 10.1186/s12902-025-01833-3.
Progressive Cachexia: Tuberculosis, Cancer, or Thyrotoxicosis? Disease-Directed Therapy and Atypical Courses of Autoimmune and Malignant Thyroid Diseases in a High Specialization Era: Case-Control Study with a Critical Literature Review.
Zdziarski P, Sroka Z
Biomedicines. 2025; 12(12.
PMID: 39767631
PMC: 11727103.
DOI: 10.3390/biomedicines12122722.
Outcome analysis of differentiated thyroid cancer: Experience from tertiary care in Karachi.
Furqan S, Ahmed A, Batool S, Islam N
Pak J Med Sci. 2024; 40(11):2631-2635.
PMID: 39634861
PMC: 11613377.
DOI: 10.12669/pjms.40.11.7036.
The Role of CD56, HBME-1, and CK19 Immunohistochemical Markers in the differential Diagnosing of Thyroid Neoplasms.
Chandrakumari A, Singaravelu S, Sinha P
Niger Med J. 2024; 65(5):716-724.
PMID: 39633686
PMC: 11612330.
DOI: 10.60787/nmj-v65i3.509.
The Role of Positron Emission Tomography/Computed Tomography in the Management of Differentiated Thyroid Cancer: Current Applications and Future Perspectives.
Panagiotidis E, Zhang-Yin J
J Clin Med. 2024; 13(22).
PMID: 39598062
PMC: 11595340.
DOI: 10.3390/jcm13226918.
The differences between unilateral multifocality and bilateral multifocality in papillary thyroid carcinoma: a retrospective cohort study.
Wu Z, Gong H, Jiang Y, Jiang T, Su A
Gland Surg. 2024; 13(10):1684-1692.
PMID: 39544976
PMC: 11558291.
DOI: 10.21037/gs-24-147.
Association of the Preoperative Controlling Nutritional Status (CONUT) Score with Clinicopathological Characteristics in Patients with Papillary Thyroid Carcinoma.
Kim D, Im M, Ryang S, Kim M, Jeon Y, Kim S
Endocrinol Metab (Seoul). 2024; 39(6):856-863.
PMID: 39543965
PMC: 11695482.
DOI: 10.3803/EnM.2024.2006.
Radiation Implication in Pediatric Second Primary Thyroid Malignancy (SPTM) Cumulative Incidence and Mortality in the United States: Large Cohort Evidence.
Holmes Jr L, Simon-Plumb C, Ziegler R, Ogundele B, Holmes M, Dabney K
Cancers (Basel). 2024; 16(21).
PMID: 39518075
PMC: 11544766.
DOI: 10.3390/cancers16213637.
The role of external-beam radiotherapy for differentiated thyroid cancer.
Kawamoto T, Shikama N, Nakamura N, Mizowaki T
Jpn J Clin Oncol. 2024; 55(2):95-99.
PMID: 39498757
PMC: 11792076.
DOI: 10.1093/jjco/hyae158.
Association of BRAF V600E Mutation with Tumor Recurrence in a Small Sample of Filipino Patients with Papillary Thyroid Cancer in a Single Center.
Chiu H, Macalalad-Josue A, Corpuz D, Paragas S, Pintor O, Hernandez-Diwa M
Acta Med Philipp. 2024; 57(6):40-45.
PMID: 39483692
PMC: 11522634.
DOI: 10.47895/amp.vi0.4972.
Advancements in Hyperspectral Imaging and Computer-Aided Diagnostic Methods for the Enhanced Detection and Diagnosis of Head and Neck Cancer.
Wu I, Chen Y, Karmakar R, Mukundan A, Gabriel G, Wang C
Biomedicines. 2024; 12(10).
PMID: 39457627
PMC: 11504349.
DOI: 10.3390/biomedicines12102315.
Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases.
Kayhan Y, Azizova L, Yilmaz M, Bakis M, Kefeli M, Kan E
Arch Endocrinol Metab. 2024; 68:e230422.
PMID: 39420875
PMC: 11326733.
DOI: 10.20945/2359-4292-2023-0422.
Impact of Hashimoto's thyroiditis on the tumor microenvironment in papillary thyroid cancer: insights from single-cell analysis.
Ma H, Li G, Huo D, Su Y, Jin Q, Lu Y
Front Endocrinol (Lausanne). 2024; 15:1339473.
PMID: 39351536
PMC: 11439672.
DOI: 10.3389/fendo.2024.1339473.